Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,419 public trials 1,034 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies

NCT01805375

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +22 more
Locations
  • Royal Liverpool and Broadgreen University Hospital NHS Trust Liverpool, United Kingdom
  • The Christie NHS Foundation Trust Manchester, United Kingdom
  • The Churchill Hospital Oxford, United Kingdom
  • Derriford Hospital Plymouth, United Kingdom
View Trial Details
Completed

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00445952

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +116 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • CHU de Grenoble - Hopital de la Tronche Grenoble, France
  • German Hodgkin's Lymphoma Study Group Cologne, Germany
  • Ospedale San Martino Genoa, Italy
View Trial Details
Completed

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

NCT01460134

Conditions
Adenocarcinoma, Adnexal Diseases, Any T-cell Malignancy, +70 more
Locations
  • Mayo Clinic Arizona - Cancer Clinical Research Unit Scottsdale, Arizona, United States
  • Stanford Cancer Center - Stanford University Stanford, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine New York, United States
View Trial Details
Completed

A Safety Study of SGN-CD33A in AML Patients

NCT01902329

Conditions
Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Promyelocytic Leukemia, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Winship Cancer Institute / Emory University School of Medicine Atlanta, Georgia, United States
View all 14 locations
View Trial Details
Completed

Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

NCT00445744

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +39 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

NCT01534715

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Ohio State University Columbus, Ohio, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details

Related conditions